Dennis L. Sprecher MD
Adult Congenital Heart Disease
Penn Heart and Vascular Center Perelman Center for Advanced Medicine
Join to view full profile
3400 Civic Center Blvd# EPhiladelphia, PA 19104
Phone+1 215-615-4949
Fax+1 215-615-0829
Dr. Sprecher is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Duke University HospitalFellowship, Cardiovascular Disease, 1985 - 1986
Michael Reese Hospital/University of Illinois College of Medicine at ChicagoResidency, Internal Medicine, 1978 - 1980
Boston University School of MedicineClass of 1978
Certifications & Licensure
IL State Medical License 1979 - Present
PA State Medical License 2003 - 2026
OH State Medical License 1986 - 2020
MD State Medical License 1981 - 1993
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
Publications & Presentations
PubMed
- 4 citationsEvaluation of GSK2789917-induced TRPV4 inhibition in animal models of fluid induced lung injury.Shailesh Bihari, Melissa H Costell, Tara Bouchier, David J Behm, Mark Burgert
Naunyn-Schmiedeberg's Archives of Pharmacology. 2024-05-01 - 3 citationsEvaluation of Dynamic Contrast-Enhanced MRI Measures of Lung Congestion and Endothelial Permeability in Heart Failure: A Prospective Method Validation Study.Joseph Cheriyan, Alexandra Roberts, Caleb Roberts, Martin J Graves, Ilse Patterson
Journal of Magnetic Resonance Imaging. 2022-08-01 - 39 citationsPazopanib for severe bleeding and transfusion-dependent anemia in hereditary hemorrhagic telangiectasia.Joseph Parambil, James R. Gossage, Keith R. McCrae, Troy D. Woodard, K. V. Narayanan Menon
Angiogenesis. 2021-07-22
Press Mentions
Effect of Topical Intranasal Therapy on Epistaxis Frequency in Patients with Hereditary Hemorrhagic TelangiectasiaAugust 20th, 2018
Grant Support
- APOB Kinetics In Heterozygous LPL DeficiencyNational Heart, Lung, And Blood Institute1994–1996
- Genetic Epidemiology Of Sex Hormones And LipoproteinsEunice Kennedy Shriver National Institute Of Child Health &Human Development1991–1992
- Support For Lipid Research ClinicDivision Of Heart And Vascular Diseases1987–1990
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
